Pembrolizumab May Help in Triple-Negative Breast Cancer.
02-06-2020 19:59
By: Ed Susman - Contributing Writer - MedPage Today. Early treatment of metastatic triple-negative breast cancer with pembrolizumab (Keytruda) provided a progression-free survival benefit to women whose tumors had high levels of the agent's target PD-L1 when compared...